Paradigm Biocapital Advisors LP Q4 2024 Filing
Filed February 14, 2025
Portfolio Value
$2.9T
Holdings
28
Report Date
Q4 2024
Filing Type
13F-HR
All Holdings (28 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | NUVLNUVALENT INC | 5,363,379 | $419.8B | 14.61% | |
| 2 | ACLXARCELLX INC | 4,371,601 | $335.3B | 11.66% | |
| 3 | ARGXARGENX SE | 481,305 | $296.0B | 10.30% | |
| 4 | RVMDREVOLUTION MEDICINES INC | 6,553,111 | $286.6B | 9.97% | |
| 5 | JANXJANUX THERAPEUTICS INC | 3,515,986 | $188.2B | 6.55% | |
| 6 | TARSTARSUS PHARMACEUTICALS INC | 2,531,896 | $140.2B | 4.88% | |
| 7 | EWTXEDGEWISE THERAPEUTICS INC | 4,493,929 | $120.0B | 4.17% | |
| 8 | PCVXVAXCYTE INC | 1,422,787 | $116.5B | 4.05% | |
| 9 | ONCBEIGENE LTD | 616,024 | $113.8B | 3.96% | |
| 10 | CRNXCRINETICS PHARMACEUTICALS IN | 1,910,761 | $97.7B | 3.40% | |
| 11 | MLTXMOONLAKE IMMUNOTHERAPEUTICS | 1,772,211 | $96.0B | 3.34% | |
| 12 | IRONDISC MEDICINE INC | 1,497,720 | $95.0B | 3.30% | |
| 13 | MRUSMERUS N V | 1,689,922 | $71.1B | 2.47% | |
| 14 | VERAVERA THERAPEUTICS INC | 1,437,339 | $60.8B | 2.11% | |
| 15 | APGEAPOGEE THERAPEUTICS INC | 1,283,766 | $58.2B | 2.02% | |
| 16 | OLMAOLEMA PHARMACEUTICALS INC | 7,304,970 | $42.6B | 1.48% | |
| 17 | PLRXPLIANT THERAPEUTICS INC | 3,197,050 | $42.1B | 1.46% | |
| 18 | IMTXIMMATICS N.V | 5,414,409 | $38.5B | 1.34% | |
| 19 | COGTCOGENT BIOSCIENCES INC | 4,917,412 | $38.4B | 1.33% | |
| 20 | SYRESPYRE THERAPEUTICS INC | 1,527,205 | $35.6B | 1.24% | |
| 21 | VRDNVIRIDIAN THERAPEUTICS INC | 1,820,079 | $34.9B | 1.21% | |
| 22 | YMABUSDY-MABS THERAPEUTICS INC | 4,236,346 | $33.2B | 1.15% | |
| 23 | ERASERASCA INC | 10,752,354 | $27.0B | 0.94% | |
| 24 | TECXTECTONIC THERAPEUTIC INC | 485,105 | $22.4B | 0.78% | |
| 25 | LENZLENZ THERAPEUTICS INC | 770,455 | $22.2B | 0.77% | |
| 26 | SRRKSCHOLAR ROCK HLDG CORP | 400,000 | $17.3B | 0.60% | |
| 27 | ORKAORUKA THERAPEUTICS INC | 819,660 | $15.9B | 0.55% | |
| 28 | AGIOAGIOS PHARMACEUTICALS INC | 276,439 | $9.1B | 0.32% |